Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Option for Hepatitis B and C: a French Cohort

NCT01953458 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.

NCT NCT01953458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01953458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Option for Hepatitis B and C: a French Cohort
Lead sponsor
ANRS, Emerging Infectious Diseases
Phase
Observational
Overall status
Unknown status
Start date
August 6, 2012
Completion date
December 31, 2024
Enrollment
20,902 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

viral hepatitis b, viral hepatitis c